YcjW is a LacI/GalR-family transcriptional repressor that regulates genes involved in emergency H₂S biosynthesis and antibiotic tolerance . Key features include:
DNA-binding domain: N-terminal helix-turn-helix motif for target recognition
Ligand-binding domain: C-terminal region that modulates repression activity
Regulon: Controls the ycjMNOPQRSTUV-ompG operon and pspE, a thiosulfate sulfurtransferase gene
The antibody has been instrumental in:
Identified YcjW binding peaks upstream of ycjM and ycjU, confirming its role as a repressor .
Revealed differential DNA occupancy between wild-type YcjW and its S258N mutant variant .
Validated YcjW-DNA interactions using 50-bp probes containing the conserved 14-bp motif (5’-TGTTAATCGAATACA-3’) .
Demonstrated equivalent DNA-binding affinity for wild-type and S258N YcjW at 1:0.5 DNA:protein ratios .
| Gene | Function | Fold Change (ΔycjW vs WT) |
|---|---|---|
| ycjM | Putative transporter | 12.5x ↑ |
| ycjU | Membrane protein | 8.3x ↑ |
| ompG | Outer membrane porin | 6.7x ↑ |
| pspE | H₂S biosynthesis via thiosulfate | 4.9x ↑ |
While the cited studies utilized FLAG-tagged YcjW with immunoblot validation , broader antibody characterization challenges persist in biomedical research . Best practices include:
YcjW is an annotated putative member of the LacI/GalR family of repressors primarily responsible for carbohydrate metabolism in Escherichia coli. It features an N-terminal helix-turn-helix DNA-binding domain, a linker domain, and a C-terminal ligand-binding domain. Research has revealed that YcjW plays a significant role in controlling emergency hydrogen sulfide (H₂S) production, which has implications for antibiotic tolerance mechanisms in bacteria . The study of ycjW provides important insights into bacterial adaptation mechanisms, stress responses, and potential targets for antimicrobial interventions, making the ycjW antibody a valuable research tool for investigating these cellular processes.
YcjW antibodies are primarily used in research applications such as Western Blotting (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) . These antibodies facilitate the detection and quantification of the ycjW transcription factor in experimental samples. In research contexts, they are particularly valuable for chromatin immunoprecipitation sequencing (ChIP-seq) experiments to map the genome-wide binding sites of ycjW, as demonstrated in studies investigating the YcjW regulon in vivo . Additionally, ycjW antibodies can be employed in immunoprecipitation assays to isolate protein complexes containing ycjW, allowing researchers to identify interaction partners and further elucidate its regulatory networks.
Commercially available ycjW antibodies are typically polyclonal antibodies raised in rabbits against recombinant Escherichia coli (strain K12) ycjW protein . They are generally supplied in liquid form with preservatives such as 0.03% Proclin 300 and storage buffer constituents including 50% glycerol and 0.01M PBS at pH 7.4 . These antibodies undergo purification through antigen affinity methods to ensure specificity. They demonstrate reactivity specifically with Escherichia coli (strain K12) and are validated for applications such as ELISA and Western blotting . Proper storage at -20°C or -80°C is recommended to maintain antibody integrity, with precautions to avoid repeated freeze-thaw cycles .
Validating ycjW antibody specificity requires a multi-faceted approach. Begin with positive and negative controls: use purified recombinant ycjW protein as a positive control and cellular extracts from ycjW knockout strains (ΔycjW) as negative controls . Western blot analysis should show a single band at the expected molecular weight (~38 kDa) in wild-type samples and absence in knockout samples. For ChIP applications, perform ChIP-qPCR targeting known binding sites such as those upstream of ycjM and between ycjT and ycjU, which have been confirmed in previous studies . Additionally, compare binding patterns between wild-type YcjW and the S258N variant to evaluate binding specificity differences. Cross-reactivity testing should be conducted against related LacI/GalR family proteins. Finally, peptide competition assays can be performed by pre-incubating the antibody with excess purified ycjW protein, which should abolish specific signals in subsequent applications.
When conducting ChIP-seq with ycjW antibodies, several methodological considerations are crucial for obtaining reliable results. First, proper epitope tagging strategies should be employed, such as the 3xFLAG tag used successfully in previous studies . This approach can enhance antibody recognition and specificity. Crosslinking conditions must be optimized; standard formaldehyde (1%) for 10-20 minutes is typically effective for DNA-binding proteins like ycjW, but optimization may be necessary depending on specific experimental conditions.
For sonication, parameters should be adjusted to generate DNA fragments between 200-500 bp for optimal resolution. Immunoprecipitation requires careful antibody titration to determine the optimal antibody-to-chromatin ratio. Based on previous successful experiments, a DNA:protein ratio beginning at 1:0.5 has proven effective for observing YcjW-DNA complex formation in vitro .
Control experiments are critical and should include input DNA, mock IP (no antibody), and ideally a non-specific antibody control. For ycjW specifically, include comparative ChIP-seq with both wild-type YcjW and the S258N variant to identify differential binding patterns . During data analysis, peak calling algorithms like MACS2 have been successfully employed for ycjW ChIP-seq data analysis . Validation of identified binding sites through EMSA or ChIP-qPCR is also recommended, particularly focusing on sites with the strongest enrichment such as those near ycjM, ycjT, and ycjU .
Mutations in ycjW can significantly alter its regulatory function as demonstrated by the S258N substitution, which restores H₂S production and antibiotic tolerance in ΔmstA-sup strains . This single amino acid change in the C-terminal domain affects the protein's effector pocket, potentially broadening specificity of inducer recognition, altering co-repressor binding affinity, or modifying oligomerization properties .
Antibodies can help investigate these functional changes through several methodological approaches. First, researchers can use ycjW antibodies in ChIP-seq experiments to compare genome-wide binding profiles between wild-type and mutant variants (such as YcjW S258N) . This approach can reveal shifts in binding site preferences or affinity changes. Second, immunoprecipitation followed by mass spectrometry can identify differences in protein interaction partners between wild-type and mutant ycjW. Third, immunofluorescence microscopy with ycjW antibodies can track changes in subcellular localization resulting from mutations.
For functional studies, combine immunoblotting with reporter gene assays to correlate ycjW protein levels (detected via antibodies) with transcriptional repression activity. Specifically for the S258N mutation, studies have shown upregulation of target genes such as ycjM, ycjT, ycjU, and ompG in strains expressing the mutant variant . Finally, antibodies recognizing phosphorylation or other post-translational modifications can determine if mutations affect these regulatory mechanisms in ycjW.
For optimal Western blot applications with ycjW antibodies, begin sample preparation using bacterial cultures in mid-logarithmic phase (OD₆₀₀ ≈ 0.5-0.7) to ensure consistent protein expression. Lyse cells in a buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Triton X-100, and protease inhibitors. For SDS-PAGE, load 10-30 μg of total protein per lane on 10-12% polyacrylamide gels, as ycjW is approximately 38 kDa.
During transfer, use PVDF membranes with a pore size of 0.45 μm and transfer at 100V for 1 hour or 30V overnight at 4°C in Tris-glycine buffer with 20% methanol. For blocking, use 5% non-fat milk in TBST (TBS with 0.1% Tween-20) for 1 hour at room temperature. The primary ycjW antibody should be diluted at 1:1000 to 1:5000 in blocking buffer and incubated overnight at 4°C .
For detection, use HRP-conjugated anti-rabbit secondary antibodies at 1:5000 to 1:10000 dilution with incubation for 1 hour at room temperature. Include appropriate controls: wild-type E. coli extracts as positive control and ΔycjW strain extracts as negative control . If detecting tagged versions (such as 3xFLAG-tagged YcjW), adjust antibody selection accordingly . Visualization can be performed using enhanced chemiluminescence (ECL) with exposure times typically between 30 seconds to 5 minutes depending on expression levels and antibody sensitivity.
YcjW antibodies can be instrumental in studying protein-DNA interactions within regulatory networks through several methodological approaches. Chromatin immunoprecipitation (ChIP) is the primary technique, where ycjW antibodies are used to isolate DNA fragments bound by ycjW in vivo. For ChIP-qPCR, design primers targeting specific regulatory regions such as those upstream of ycjM or between ycjT and ycjU, which have been identified as strong binding sites .
For genome-wide binding studies, ChIP-seq can be performed using antibodies against either native ycjW or epitope-tagged versions (such as 3xFLAG-tagged YcjW) . DNA fragments immunoprecipitated with ycjW antibodies are sequenced and aligned to the reference genome. Peak calling algorithms like MACS2 can be used to identify enriched regions representing ycjW binding sites .
To validate direct binding to specific DNA sequences, perform electrophoretic mobility shift assays (EMSA) using purified ycjW protein and DNA probes containing predicted binding sequences. Previous studies have shown that both wild-type and S258N ycjW proteins bind DNA probes at approximately 1:0.5 DNA:protein ratios .
DNA footprinting assays with ycjW antibodies can precisely map the binding sites at nucleotide resolution. For investigating the impact of ycjW binding on gene expression, combine ChIP with RNA-seq or qRT-PCR analyses to correlate binding events with transcriptional changes. For example, genes regulated by ycjW (ycjM, ycjT, ycjU, and ompG) show significant upregulation in ΔycjW strains, confirming ycjW's role as a repressor .
YcjW plays a significant role in antibiotic tolerance mechanisms through its regulation of emergency hydrogen sulfide (H₂S) production in Escherichia coli . The S258N substitution in ycjW has been shown to restore both H₂S production and antibiotic tolerance in ΔmstA-sup strains, allowing increased survival when challenged with antibiotics like gentamicin, as well as with H₂O₂ and nalidixic acid .
Researchers can use ycjW antibodies to elucidate these tolerance pathways through several methodological approaches. First, ChIP-seq experiments using ycjW antibodies can map the complete regulon under different antibiotic stress conditions, revealing stress-specific binding patterns. Comparative ChIP-seq between antibiotic-treated and untreated cells can identify regulatory shifts in ycjW binding during stress responses .
Co-immunoprecipitation (Co-IP) with ycjW antibodies followed by mass spectrometry can identify protein interaction partners that mediate antibiotic tolerance mechanisms. Time-course studies combining immunoblotting with ycjW antibodies and measurements of H₂S production can establish the temporal relationship between ycjW regulation and protective H₂S generation.
For functional analyses, researchers can correlate ycjW binding (measured via ChIP) with expression changes in genes like pspE, which has been implicated in H₂S production and antibiotic tolerance . Additionally, immunofluorescence microscopy with ycjW antibodies can track changes in ycjW localization during antibiotic stress. Finally, phospho-specific antibodies can determine if post-translational modifications of ycjW occur during stress responses, potentially affecting its regulatory function in antibiotic tolerance pathways.
Several common challenges arise when working with ycjW antibodies, each requiring specific troubleshooting approaches. For non-specific binding issues, optimize blocking conditions by testing different blocking agents (BSA, casein, or commercial blocking solutions) and increasing blocking time to 2 hours. Pre-adsorb the antibody with E. coli lysate from ΔycjW strains to remove non-specific antibodies.
When facing weak signal strength, ensure proper antibody storage at -20°C or -80°C and avoid repeated freeze-thaw cycles . Increase antibody concentration gradually and extend primary antibody incubation time to overnight at 4°C. Consider using signal enhancement systems such as biotin-streptavidin amplification for detection.
For high background noise, increase washing frequency and duration (5-6 washes of 10 minutes each) with TBST or PBST buffers. Reduce secondary antibody concentration and ensure all reagents are fresh. For Western blot applications specifically, use freshly prepared buffers and increase the concentration of Tween-20 in wash buffers to 0.1-0.2%.
Cross-reactivity with related LacI/GalR family proteins can be addressed by performing competitive binding assays with recombinant proteins from this family. For ChIP applications specifically, optimize crosslinking conditions by testing different formaldehyde concentrations (0.5-2%) and incubation times (5-20 minutes). Finally, batch-to-batch variability can be minimized by purchasing larger quantities of a single lot when possible and performing extensive validation with each new antibody lot using positive controls of ycjW-expressing cells.
Enhancing sensitivity for ycjW antibody-based assays in low-expression systems requires multiple optimization strategies. First, implement signal amplification techniques such as tyramide signal amplification (TSA) for immunohistochemistry or Western blotting, which can increase sensitivity by 10-100 fold. For Western blots, consider using high-sensitivity ECL substrates designed for detecting low-abundance proteins.
Concentration of target protein can be achieved through immunoprecipitation prior to analysis, enriching ycjW from larger sample volumes before detection. For bacterial samples, optimize induction conditions if using inducible expression systems, or harvest cells at growth phases when ycjW expression is naturally highest.
Technical modifications to improve detection include using highly sensitive detection methods such as quantitative chemiluminescence or fluorescence-based systems with digital imaging. For Western blots, transfer efficiency can be improved by using semi-dry transfer systems with optimized buffer composition for proteins in ycjW's molecular weight range (approximately 38 kDa).
For ChIP applications in low-expression systems, increase starting material (2-3 times normal amount) and optimize sonication conditions to ensure efficient chromatin fragmentation. Consider using ChIP-exo or ChIP-nexus protocols, which provide higher resolution and sensitivity than standard ChIP-seq.
Epitope tags can significantly enhance detection when native protein levels are low, as demonstrated in previous studies using 3xFLAG-tagged YcjW for ChIP-seq experiments . Finally, consider using proximity ligation assays (PLA) which can detect single protein molecules through rolling circle amplification, providing significantly higher sensitivity than traditional immunoassays.
When using ycjW antibodies to study post-translational modifications (PTMs) or protein-protein interactions, several methodological considerations are critical. First, determine if the ycjW antibody epitope overlaps with potential PTM sites, as modifications might mask antibody recognition. Consider using multiple antibodies targeting different regions of ycjW to ensure comprehensive detection. For PTM studies specifically, compare results between pan-ycjW antibodies and modification-specific antibodies (such as phospho-specific antibodies) if available.
For protein-protein interaction studies, optimize immunoprecipitation conditions by testing different lysis buffers with varying salt concentrations (150-300 mM NaCl) and detergent types (Triton X-100, NP-40, CHAPS) to preserve interactions while ensuring efficient extraction. Crosslinking agents like DSS or formaldehyde can stabilize transient interactions before immunoprecipitation with ycjW antibodies.
When designing co-immunoprecipitation experiments, pre-clear lysates with protein A/G beads to reduce non-specific binding. Use appropriate controls including IgG control immunoprecipitations and reciprocal co-IPs when possible. For detecting subtle PTMs or low-abundance interaction partners, consider using mass spectrometry following immunoprecipitation with ycjW antibodies.
For studying the relationship between ycjW's PTMs and DNA binding, combine ChIP-seq with PTM-specific antibodies or perform sequential ChIP (re-ChIP) experiments. When investigating how ligands like kojibiose affect ycjW's interactions , perform binding assays in the presence and absence of the ligand before immunoprecipitation.
Finally, be aware that the C-terminal region of ycjW, particularly around residue S258, is critical for function as shown by the S258N mutation's effects . Antibodies targeting this region might be sensitive to conformational changes induced by effector binding or mutations.
Research on ycjW provides significant insights into bacterial adaptation mechanisms, particularly in response to environmental stresses and antibiotic challenges. The discovery that a single nucleotide polymorphism (SNP) in ycjW (S258N) can restore H₂S production and antibiotic tolerance in ΔmstA strains highlights the remarkable genetic plasticity employed by bacteria to rapidly adapt to environmental changes . This adaptation mechanism represents a sophisticated regulatory network linking carbohydrate metabolism to stress response systems.
YcjW's role as a repressor in the LacI/GalR family reveals how bacteria tightly regulate carbon metabolism genes in response to available nutrients . When derepressed, as in the S258N mutant, YcjW alters the expression of genes involved in rare sugar metabolism (such as kojibiose) and simultaneously affects the expression of genes like pspE that contribute to H₂S production . This pleiotropic effect demonstrates how bacteria can repurpose existing regulatory networks to develop stress tolerance.
The relationship between YcjW, carbohydrate metabolism, and H₂S production suggests a previously unrecognized link between nutrient availability and stress response mechanisms . This connection may represent an evolutionary adaptation where changes in carbon source availability trigger protective mechanisms anticipating other environmental stresses. Furthermore, the S258N mutation in YcjW's C-terminal effector pocket illustrates how subtle alterations in transcription factor structure can dramatically reshape bacterial gene expression patterns and phenotypic outcomes .
Understanding these adaptive mechanisms has implications for addressing antimicrobial resistance, as YcjW's connection to H₂S production directly influences antibiotic tolerance mechanisms . This research provides potential targets for developing novel therapeutics that could disrupt these adaptation pathways to enhance the efficacy of existing antibiotics.
Several cutting-edge technologies are enhancing antibody-based investigation of transcription factors like ycjW. Single-molecule imaging approaches such as single-molecule tracking (SMT) use fluorescently labeled antibodies to track individual transcription factor molecules in living cells, revealing dynamic binding behaviors, residence times, and diffusion patterns. Proximity labeling methods like BioID and APEX2 can be coupled with ycjW antibodies to identify proteins within the ycjW microenvironment, providing spatial context to interaction networks.
In the field of structural biology, advances in cryo-electron microscopy now allow visualization of antibody-bound transcription factor complexes at near-atomic resolution. This technique could potentially reveal how the S258N mutation alters YcjW's structure and DNA binding properties . Mass cytometry (CyTOF) combined with ycjW antibodies enables multiplexed protein detection across bacterial populations, revealing heterogeneity in ycjW expression and potential subpopulations with distinct regulatory states.
For chromatin-associated studies, advanced methodologies include CUT&RUN and CUT&Tag, which offer higher sensitivity and lower background than traditional ChIP methods for mapping transcription factor binding sites. CUT&Tag specifically uses antibody-directed tagmentation to map protein-DNA interactions with reduced input material requirements. Microfluidic platforms are enabling high-throughput ChIP assays with minimal sample consumption, allowing parallel analysis of multiple conditions or time points.
Computational approaches are increasingly integrated with antibody-based methods, with machine learning algorithms being developed to predict transcription factor binding sites and regulatory networks based on ChIP-seq data . Finally, CRISPR-based transcription factor fusion systems allow targeted recruitment of ycjW to specific genomic loci, with antibodies used to verify binding and subsequent effects on gene expression.
The relationship between ycjW regulation and bacterial stress responses reveals a sophisticated adaptive mechanism centered on emergency H₂S production. YcjW functions as a transcriptional repressor that, when mutated (S258N) or derepressed, enables increased H₂S production through mechanisms including the upregulation of pspE, contributing to enhanced antibiotic tolerance and oxidative stress resistance . This regulatory network demonstrates how bacteria can repurpose carbon metabolism regulators to respond to antimicrobial challenges.
Specifically, the YcjW regulon primarily controls genes involved in carbohydrate metabolism pathways, particularly those related to rare sugars like kojibiose . The link between this metabolic regulation and stress responses suggests that changes in nutrient availability serve as environmental cues that trigger protective mechanisms. The allosteric regulation of YcjW by kojibiose further highlights how specific metabolites can modulate transcriptional responses .
This research has several implications for antimicrobial development strategies. First, targeting H₂S production pathways could potentially enhance the efficacy of existing antibiotics by preventing bacteria from deploying this protective mechanism. Specifically, developing small molecule inhibitors of YcjW's interaction with its DNA targets or with allosteric regulators like kojibiose could disrupt this stress response pathway.
Second, the observed phenotypic suppression in ΔmstA-sup strains through the S258N mutation in YcjW highlights the genetic plasticity that bacteria employ to overcome growth defects . This adaptability must be considered when designing antimicrobial strategies to avoid rapid resistance development. Targeting multiple components of the stress response pathway simultaneously might reduce the likelihood of compensatory mutations.
Finally, the connection between carbohydrate availability and stress tolerance suggests that manipulating bacterial metabolism could potentially sensitize pathogens to antimicrobial treatments. Combination therapies that simultaneously target metabolic pathways and apply conventional antibiotics might overcome tolerance mechanisms regulated by transcription factors like YcjW, providing a promising direction for addressing the growing challenge of antimicrobial resistance.
| Property | Specification |
|---|---|
| Product Code | CSB-PA300601XA01ENV |
| Storage Conditions | -20°C or -80°C (avoid repeated freeze-thaw) |
| Immunogen | Recombinant Escherichia coli (strain K12) ycjW protein |
| Host Species | Rabbit |
| Species Reactivity | Escherichia coli (strain K12) |
| Validated Applications | ELISA, Western Blot |
| Form | Liquid |
| Conjugate | Non-conjugated |
| Storage Buffer | 0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4 |
| Purification Method | Antigen Affinity Purified |
| Isotype | IgG |
| Clonality | Polyclonal |
| Lead Time | Made-to-order (14-16 weeks) |
| Usage | For Research Use Only |
Table data sourced from commercial antibody specifications
| Rank | Keywords | Count | Rank | Keywords | Count |
|---|---|---|---|---|---|
| 1 | ADCs (antibody-drug conjugates) | 762 | 11 | drug delivery | 74 |
| 2 | breast cancer | 380 | 12 | EGFR (epidermal growth factor receptor) | 71 |
| 3 | target therapy | 220 | 13 | HER2-low | 70 |
| 4 | HER-2 (human epidermal growth factor receptor-2) | 208 | 14 | trastuzumab deruxtecan | 70 |
| 5 | immunotherapy | 186 | 15 | ovarian cancer | 69 |
| 6 | T-DM1 (trastuzumab emtansine) | 142 | 16 | antibodies | 68 |
| 7 | trastuzumab | 105 | 17 | checkpoint inhibitors | 63 |
| 8 | TNBC (triple negative breast cancer) | 96 | 18 | sacituzumab govitecan | 63 |
| 9 | monoclonal antibodies | 93 | 19 | NSCLC (non-small-cell lung cancer) | 60 |
| 10 | cancer | 90 | 20 | Trop-2 (trophoblast surface antigen 2) | 60 |
Table showing frequency of keywords in antibody research literature
| Gene | Function | Expression in ΔycjW | Expression in YcjW (S258N) | Binding Confirmation Method |
|---|---|---|---|---|
| ycjM | Predicted glycoside hydrolase | Significantly upregulated | Upregulated | ChIP-seq, EMSA, qRT-PCR |
| ycjT | Kojibiose phosphorylase | Significantly upregulated | Upregulated | ChIP-seq, qRT-PCR |
| ycjU | Predicted sugar isomerase | Significantly upregulated | Upregulated | ChIP-seq, qRT-PCR |
| ompG | Outer membrane porin | Significantly upregulated | Upregulated | ChIP-seq, qRT-PCR |
| pspE | Thiosulfate sulfurtransferase | Moderately upregulated | Upregulated | Indirect regulation, qRT-PCR |
| narP | Nitrate/nitrite response regulator | No significant change | Unknown | ChIP-seq, EMSA |
| cyaA | Adenylate cyclase | No significant change | Unknown | ChIP-seq |
Table compiled from experimental data reported in research on YcjW regulation